Erratum: Partial breast irradiation: New standard for selected patients (Lancet (2010) DOI: 10.1016/S0140-6736(10)60898-7);Partial breast irradiation: New standard for selected patients

The Lancet

Volumn 376, Issue 9735, 2010, Pages 71-72

  Azria, David ^a   Bourgier, Céline ^b  

^a CENTRE VAL D AURELLE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST TUMOR; CANCER CONTROL; FROZEN SECTION; HUMAN; INTRADUCTAL CARCINOMA; INTRAOPERATIVE RADIOTHERAPY; NOTE; PRIORITY JOURNAL; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 77955012983     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60898-7     Document Type: Erratum

References (13)

1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-2106
2. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007; 25: 3259-3265
3. Dubois JB, Hay M, Gely S, Saint-Aubert B, Rouanet P, Pujol H. IORT in breast carcinomas. Front Radiat Ther Oncol 1997; 31: 131-137
4. Lemanski C, Azria D, Gourgon-Bourgade S, et al. Intraoperative radiotherapy in early-stage breast cancer: results of the Montpellier phase II trial. Int J Radiat Oncol Biol Phys 2010; 76: 698-703.
5. Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010; published online June 5. DOI:10.1016/S0140-6736(10)60837-9.
6. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009; 74: 987-1001.
7. Hughes KS, Schnaper LA, Berry D, et al, for the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and Eastern Cooperative Oncology Group. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004; 351: 971-977
8. Fisher B, Bryant J, Dignam JJ, et al, for the National Surgical Adjuvant Breast and Bowel Project. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002; 20: 4141-4149
9. Bourgier C, Khodari W, Vataire AL, et al. Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease. Radiother Oncol 2010; published online March 26. DOI:10.1016/j.radonc. 2010.02.028.
10. Azria D, Belkacemi Y, Romieu G, et al. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol 2010; 11: 258-265
11. Bourgier C, Marsiglia H, Taghian A. A mixed-modality 3D-conformal accelerated partial breast irradiation technique using opposed mini-tangent photon fields and en face electrons to minimize the lung exposure to radiation: in regard to Jain et al. (Int J Radiat Oncol Biol Phys 2009; 75: 82-88).
12. Int J Radiat Oncol Biol Phys 2010; 76: 956-957.
13. Anon. Radiation therapy in treating women who have undergone surgery for ductal carcinoma in situ or stage I or stage II breast cancer. May 25, 2010. http://clinicaltrials.gov/ct/show/NCT00103181 (accessed May 28, 2010).